Insider Trading & Ownership - HAUMANN BRETT K

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for HAUMANN BRETT K
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-08-21
Sale
2020-08-24
6:21 pm
Theravance Biopharma Inc.TBPHHAUMANN BRETT K
Chief Medical Officer
25,000$18.29$457,240282,810
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-02-20
Tax Withholding
2021-02-23
6:05 pm
N/A
N/A
Theravance Biopharma Inc.TBPHHAUMANN BRETT K
Chief Medical Officer
35,672$18.79242,499
(Direct)
View
2020-11-20
Tax Withholding
2020-11-24
6:16 pm
N/A
N/A
Theravance Biopharma Inc.TBPHHAUMANN BRETT K
Chief Medical Officer
4,639$17.21278,171
(Direct)
View
2020-10-10
Equity Swap
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTHAUMANN BRETT K
Director
6,250$34.50
(Direct)
View
2020-10-13
Disposition
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTHAUMANN BRETT K
Director
25,453$17.390
(Direct)
View
2020-10-13
Disposition
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTHAUMANN BRETT K
Director
13,313$34.50
(Direct)
View
2020-08-20
Tax Withholding
2020-08-24
6:21 pm
N/A
N/A
Theravance Biopharma Inc.TBPHHAUMANN BRETT K
Chief Medical Officer
4,646$18.22282,810
(Direct)
View
2020-05-27
Option Award
2020-05-29
7:17 pm
N/A
2030-05-26
Aimmune Therapeutics Inc.AIMTHAUMANN BRETT K
Director
38,766$045,016
(Direct)
View
2020-05-20
Tax Withholding
2020-05-22
6:06 pm
N/A
N/A
Theravance Biopharma Inc.TBPHHAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
4,212$26.67312,456
(Direct)
View
2020-02-20
Tax Withholding
2020-02-24
7:07 pm
N/A
N/A
Theravance Biopharma Inc.TBPHHAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
33,608$25.9316,668
(Direct)
View
2020-02-03
Option Award
2020-02-05
6:57 pm
N/A
N/A
Theravance Biopharma Inc.TBPHHAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
119,000$0350,276
(Direct)
View